Hengrui Halts Most Generic Development After Prices Free Fall In China

 
• By Brian Yang
  
HENGRUI REPORTEDLY HALTs MOST GENERICS DEVELOPMENT AFTER HUGE PRICE FALL • Source: Scrip
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia